We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
PUT
Sweetgreen
SG
$732M
| $993K | ﹤0.01% |
28,000
-151,100
| -84% | -$4.59M |
|
2602
Viridian Therapeutics
VRDN
$2.15B
| $991K | ﹤0.01% |
43,579
-99,357
| -70% | -$1.62M |
|
|
PRSU
2603
Pursuit Attractions and Hospitality Inc
PRSU
$1.46B
| $991K | ﹤0.01% |
27,666
+20,956
| +312% | +$713K |
|
2604
PUT
Alnylam Pharmaceuticals
ALNY
$38.6B
| $990K | ﹤0.01% |
3,600
+2,400
| +200% | +$625K |
|
2605
iShares MSCI USA Quality Factor ETF
QUAL
$46.1B
| $990K | ﹤0.01% |
5,520
+2,018
| +58% | +$350K |
|
2606
Cimpress
CMPR
$2.45B
| $985K | ﹤0.01% |
12,028
+7,000
| +139% | +$621K |
|
2607
CALL
Axalta
AXTA
$7.68B
| $984K | ﹤0.01% |
27,200
-71,200
| -72% | -$2.5M |
|
2608
Federated Hermes
FHI
$4.53B
| $983K | ﹤0.01% |
26,730
+9,528
| +55% | +$326K |
|
2609
Transcat
TRNS
$806M
| $983K | ﹤0.01% |
+8,138
| New | +$1.01M |
|
2610
Denali Therapeutics
DNLI
$3.74B
| $982K | ﹤0.01% |
33,723
-89,957
| -73% | -$2.23M |
|
2611
Empire State Realty Trust
ESRT
$971M
| $982K | ﹤0.01% |
+88,585
| New | +$924K |
|
|
CFB
2612
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $981K | ﹤0.01% |
+58,782
| New | +$991K |
|
|
GOOS
2613
Canada Goose Holdings
GOOS
$892M
| $980K | ﹤0.01% |
78,199
+59,248
| +313% | +$672K |
|
2614
Rocket Pharmaceuticals
RCKT
$346M
| $980K | ﹤0.01% |
+53,039
| New | +$1.09M |
|
|
SPR
2615
PUT
DELISTED
Spirit AeroSystems
SPR
| $975K | ﹤0.01% |
30,000
-45,000
| -60% | -$1.54M |
|
2616
CALL
TeraWulf
WULF
$8.19B
| $974K | ﹤0.01% |
208,200
-422,600
| -67% | -$1.92M |
|
2617
CALL
American International
AIG
$42.8B
| $974K | ﹤0.01% |
13,300
-7,400
| -36% | -$552K |
|
2618
CALL
iShares US Medical Devices ETF
IHI
$3.17B
| $971K | ﹤0.01% |
16,400
-4,100
| -20% | -$234K |
|
2619
CALL
Magnite
MGNI
$2.74B
| $971K | ﹤0.01% |
70,100
-88,700
| -56% | -$1.21M |
|
2620
CALL
Coherent
COHR
$45.8B
| $969K | ﹤0.01% |
10,900
-105,400
| -91% | -$7.88M |
|
2621
PUT
Automatic Data Processing
ADP
$106B
| $969K | ﹤0.01% |
+3,500
| New | +$915K |
|
2622
Baker Hughes
BKR
$59.3B
| $967K | ﹤0.01% |
26,747
-298
| -1% | -$10.5K |
|
2623
Gentherm
THRM
$1.3B
| $966K | ﹤0.01% |
20,759
-40,753
| -66% | -$2.02M |
|
2624
ResMed
RMD
$30.2B
| $966K | ﹤0.01% |
3,957
-24
| -0.6% | -$5.36K |
|
2625
HCI Group
HCI
$2.28B
| $965K | ﹤0.01% |
+9,009
| New | +$854K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.